Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
INF
Brookfield Glbl Lstd Infrstr Incm Fd
$12.81
$12.81
$11.89
$15.67
$172.72M1.2980,544 shs50,543 shs
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
$2.51
+6.4%
$2.79
$1.72
$15.70
$3.03M0.17553,622 shs96,134 shs
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
$0.00
$0.00
$0.00
N/AN/A43,716 shs4,125 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
INF
Brookfield Glbl Lstd Infrstr Incm Fd
0.00%0.00%0.00%0.00%0.00%
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
+6.36%-1.57%-9.06%-10.68%-54.51%
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
INF
Brookfield Glbl Lstd Infrstr Incm Fd
N/AN/AN/AN/AN/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
0.7545 of 5 stars
0.04.00.00.02.40.00.6
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
INF
Brookfield Glbl Lstd Infrstr Incm Fd
0.00
N/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
0.00
N/AN/AN/A
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
INF
Brookfield Glbl Lstd Infrstr Incm Fd
N/AN/AN/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
$4.60M0.66N/AN/A$20.64 per share0.12
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
INF
Brookfield Glbl Lstd Infrstr Incm Fd
N/AN/A0.00N/AN/AN/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
-$7.68M-$12.09N/AN/A-168.87%-107.93%-82.97%N/A
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest INM, TNI, INF, and PSON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q3 2025
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
N/A-$1.94N/A-$1.94N/A$1.26 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
INF
Brookfield Glbl Lstd Infrstr Incm Fd
$0.987.65%N/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
N/AN/AN/AN/AN/A
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
INF
Brookfield Glbl Lstd Infrstr Incm Fd
N/AN/AN/A
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
0.06
3.49
3.04
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
INF
Brookfield Glbl Lstd Infrstr Incm Fd
25.13%
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
20.12%
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
INF
Brookfield Glbl Lstd Infrstr Incm Fd
N/A13.48 millionN/ANot Optionable
InMed Pharmaceuticals Inc. stock logo
INM
InMed Pharmaceuticals
101.21 million1.19 millionNot Optionable
Petrosonic Energy Inc stock logo
PSON
Petrosonic Energy
21,400N/AN/ANot Optionable

Recent News About These Companies

Iowa researchers shine light on the future of energy use
Energy plant workers learn about new benefits
Associated Person: What It Is, How It Works

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

Brookfield Glbl Lstd Infrstr Incm Fd NYSE:INF

Brookfield Global Listed Infrastructure Income Fund Inc. is a closed-ended equity mutual fund launched and managed by Brookfield Investment Management Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the infrastructure sector. The fund employs fundamental analysis with a bottom-up stock picking approach, focusing on factors such as temporary market mispricing, values of assets, and cash flows to create its portfolio. It conducts in-house research to make its investments. Brookfield Global Listed Infrastructure Income Fund Inc. was formed on June 8, 2011 and is domiciled in the United States.

InMed Pharmaceuticals stock logo

InMed Pharmaceuticals NASDAQ:INM

$2.51 +0.15 (+6.36%)
Closing price 06/18/2025 04:00 PM Eastern
Extended Trading
$2.48 -0.03 (-1.39%)
As of 06/18/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Petrosonic Energy stock logo

Petrosonic Energy OTCMKTS:PSON

Petrosonic Energy, Inc., a development stage company, focuses on the treatment and upgrading of heavy oil through sonicated solvent de-asphalting. It also intends to manufacture synthetic crude oil through emulsification of heavy crude oil and asphaltenes. The company was formerly known as Bearing Mineral Exploration, Inc. and changed its name to Petrosonic Energy, Inc. in May 2012. Petrosonic Energy, Inc. was founded in 2008 and is headquartered in Los Angeles, California.